Atrial Fibrillation

Atrial fibrillation is the most common sustained cardiac arrhythmia, characterized by rapid, disorganized electrical activity in the atria that produces an irregularly irregular ventricular response and loss of effective atrial contraction. It is a major cause of stroke, heart failure, and reduced quality of life, and its prevalence rises sharply with age. This entry summarizes its mechanisms, classification, and clinical significance as a reference topic.

Definition

Atrial fibrillation is a supraventricular tachyarrhythmia defined by uncoordinated atrial electrical activation with consequent deterioration of mechanical atrial function, recognized on the electrocardiogram by the absence of distinct P waves and an irregularly irregular ventricular rhythm.

Scope

The entry covers the electrophysiological basis of atrial fibrillation, its temporal classification (paroxysmal, persistent, long-standing persistent, and permanent), its principal complications — notably thromboembolic stroke — and the conceptual framework of rate control, rhythm control, and stroke-risk stratification. It is descriptive and educational and does not provide individualized clinical management or dosing.

Key concepts

• Irregularly irregular rhythm
• Absence of organized P waves
• Atrial re-entry and ectopic triggers (often pulmonary vein foci)
• Paroxysmal, persistent, and permanent classification
• Thromboembolic stroke risk
• Rate control versus rhythm control
• Stroke-risk stratification (e.g., CHA2DS2-VASc framework)

Mechanisms

Atrial fibrillation involves both triggers and a vulnerable substrate. Ectopic firing, frequently originating from sleeves of atrial myocardium around the pulmonary veins, can initiate the arrhythmia, while structural and electrical remodeling of the atria sustains it through multiple re-entrant wavelets and rotors. The disorganized atrial activation produces irregular conduction through the atrioventricular node, generating the characteristic irregularly irregular ventricular response, and loss of coordinated atrial contraction promotes blood stasis (especially in the left atrial appendage), creating the substrate for thrombus formation and embolic stroke (Hindricks et al., 2021).

Clinical relevance

Atrial fibrillation is clinically important chiefly because it markedly raises the risk of ischemic stroke and contributes to heart failure and mortality; recognizing it and understanding its risk implications is fundamental to cardiovascular care. This entry describes the condition and the evidence framework around it for educational reference and is not a guide to individual diagnosis or treatment.

Epidemiology

Atrial fibrillation is the most common sustained arrhythmia, and its prevalence increases steeply with age and with conditions such as hypertension, heart failure, valvular disease, and obesity. It is a leading attributable cause of ischemic stroke, and these strokes tend to be more severe than non-cardioembolic strokes (Hylek et al., 2003).

Evidence & guidelines

Management frameworks are codified in the ESC guidelines (Hindricks et al., 2021) and the AHA/ACC/HRS focused update (January et al., 2019). Landmark trials shaped two enduring questions: the AFFIRM trial (2002) found no survival advantage of rhythm control over rate control in its population, while CASTLE-AF (Marrouche et al., 2018) showed benefit from catheter ablation in selected patients with heart failure, illustrating how the rate-versus-rhythm debate has been refined by subgroup and technology.

History

Irregular pulse was described long before its mechanism was understood; the electrocardiographic recognition of atrial fibrillation followed Einthoven's electrocardiogram in the early twentieth century. The identification of pulmonary vein triggers in the late 1990s opened the era of catheter ablation, and the development and validation of stroke-risk scores and oral anticoagulants reshaped prevention of its most feared complication.

Debates

Rate control versus rhythm control

AFFIRM (2002) found no overall mortality benefit of pursuing rhythm control over rate control, but later trials and ablation technology — for example CASTLE-AF in heart failure — identified subgroups in which rhythm control is advantageous, keeping the optimal strategy context-dependent.

Seminal works

• hindricks-2021
• affirm-2002
• marrouche-2018

Frequently asked questions

Why does atrial fibrillation increase stroke risk?

The loss of organized atrial contraction allows blood to stagnate, particularly in the left atrial appendage, which can lead to clot formation; a dislodged clot can travel to the brain and cause an embolic stroke.

What does 'irregularly irregular' mean in atrial fibrillation?

It describes the ventricular rhythm: the intervals between beats have no repeating pattern, reflecting the chaotic and unpredictable conduction of atrial impulses through the atrioventricular node.